Cargando…

Therapeutic potential of compounds targeting SARS-CoV-2 helicase

The economical and societal impact of COVID-19 has made the development of vaccines and drugs to combat SARS-CoV-2 infection a priority. While the SARS-CoV-2 spike protein has been widely explored as a drug target, the SARS-CoV-2 helicase (nsp13) does not have any approved medication. The helicase s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Halma, Matthew T. J., Wever, Mark J. A., Abeln, Sanne, Roche, Didier, Wuite, Gijs J. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763700/ https://www.ncbi.nlm.nih.gov/pubmed/36561139 http://dx.doi.org/10.3389/fchem.2022.1062352

Ejemplares similares

Unravelling How Single-Stranded DNA Binding Protein Coordinates DNA Metabolism Using Single-Molecule Approaches
por: Xu, Longfu, et al.
Publicado: (2023)

Modelling the active SARS-CoV-2 helicase complex as a basis for structure-based inhibitor design
por: Berta, Dénes, et al.
Publicado: (2021)

Mechanism of Nucleic Acid Unwinding by SARS-CoV Helicase
por: Adedeji, Adeyemi O., et al.
Publicado: (2012)

Potential inhibitors for SARS-CoV-2 Mpro from marine compounds
por: Tam, Nguyen Minh, et al.
Publicado: (2021)

Inhibition of the SARS-CoV-2 helicase at single-nucleotide resolution
por: Marx, Sinduja K., et al.
Publicado: (2020)

Host DDX Helicases as Possible SARS-CoV-2 Proviral Factors: A Structural Overview of Their Hijacking Through Multiple Viral Proteins
por: Squeglia, Flavia, et al.
Publicado: (2020)

Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of invitro studies
por: Mehyar, Nimer
Publicado: (2023)

Inhibitors of SARS-CoV-2 PLpro
por: Calleja, Dale J., et al.
Publicado: (2022)

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase
por: Zeng, Jingkun, et al.
Publicado: (2021)

Observing inhibition of the SARS-CoV-2 helicase at single-nucleotide resolution
por: Marx, Sinduja K, et al.
Publicado: (2023)

Pharmacophore Modelling-Based Drug Repurposing Approaches for SARS-CoV-2 Therapeutics
por: Rampogu, Shailima, et al.
Publicado: (2021)

Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors
por: Calleja, Dale J., et al.
Publicado: (2022)

Repurposing potential of posaconazole and grazoprevir as inhibitors of SARS-CoV-2 helicase
por: Abidi, Syed Hani, et al.
Publicado: (2021)

Host Cellular RNA Helicases Regulate SARS-CoV-2 Infection
por: Ariumi, Yasuo
Publicado: (2022)

Regulation of T7 gp2.5 binding dynamics by its C-terminal tail, template conformation and sequence
por: Xu, Longfu, et al.
Publicado: (2023)

Recent updates on the biological efficacy of approved drugs and potent synthetic compounds against SARS-CoV-2
por: Anjani,, et al.
Publicado: (2023)

Force-Dependent Stimulation of RNA Unwinding by SARS-CoV-2 NSP13 Helicase
por: Mickolajczyk, Keith J., et al.
Publicado: (2021)

Force-dependent stimulation of RNA unwinding by SARS-CoV-2 nsp13 helicase
por: Mickolajczyk, Keith J., et al.
Publicado: (2021)

Antiviral activities of natural compounds and ionic liquids to inhibit the Mpro of SARS-CoV-2: a computational approach
por: Palanisamy, Kandhan, et al.
Publicado: (2022)

Synthesis of Hetaryl-Substituted Asymmetric Porphyrins and Their Affinity to SARS-CoV-2 Helicase
por: Syrbu, S. A., et al.
Publicado: (2021)

An immunoinformatics approach to study the epitopes of SARS-CoV-2 helicase, Nsp13
por: Kumar, Sushant, et al.
Publicado: (2023)

Nanomechanical analysis of SARS-CoV-2 variants and predictions of infectiousness and lethality
por: Hu, Yiwen, et al.
Publicado: (2022)

Antiviral cyclic peptides targeting the main protease of SARS-CoV-2
por: Johansen-Leete, Jason, et al.
Publicado: (2022)

Deducing the Crystal Structure of MERS-CoV Helicase
por: Cui, Sheng, et al.
Publicado: (2019)

Pyrazolone-type compounds: synthesis and in silico assessment of antiviral potential against key viral proteins of SARS-CoV-2
por: Branković, Jovica, et al.
Publicado: (2022)

Newly designed analogues from SARS-CoV inhibitors mimicking the druggable properties against SARS-CoV-2 and its novel variants
por: Ferdous, Nadim, et al.
Publicado: (2021)

An Enhanced Hybrid Screening Approach to Identify Potent Inhibitors for the SARS-CoV-2 Main Protease From the NCI Compound Library
por: Li, Shuhua G., et al.
Publicado: (2022)

Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex
por: Chen, James, et al.
Publicado: (2020)

Discovery of COVID-19 Inhibitors Targeting the SARS-CoV2 Nsp13 Helicase
por: White, Mark Andrew, et al.
Publicado: (2020)

Structural basis for helicase-polymerase coupling in the SARS-CoV-2 replication-transcription complex
por: Chen, James, et al.
Publicado: (2020)

Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?
por: Habtemariam, Solomon, et al.
Publicado: (2020)

Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase
por: Newman, Joseph A., et al.
Publicado: (2021)

Molecular dynamics simulations of the flexibility and inhibition of SARS-CoV-2 NSP 13 helicase
por: Raubenolt, Bryan A., et al.
Publicado: (2022)

The stalk domain of SARS-CoV-2 NSP13 is essential for its helicase activity
por: Yue, Kun, et al.
Publicado: (2022)

Computational Study of Helicase from SARS-CoV-2 in RNA-Free and Engaged Form
por: Di Matteo, Francesca, et al.
Publicado: (2022)

SARS-CoV2 billion-compound docking
por: Rogers, David M., et al.
Publicado: (2023)

In silico design of peptides with binding to the receptor binding domain (RBD) of the SARS-CoV-2 and their utility in bio-sensor development for SARS-CoV-2 detection
por: Badhe, Yogesh, et al.
Publicado: (2021)

Computational Approaches to Discover Novel Natural Compounds for SARS‐CoV‐2 Therapeutics
por: Rampogu, Shailima, et al.
Publicado: (2021)

O-Glycosylation Landscapes of SARS-CoV-2 Spike Proteins
por: Zhang, Yong, et al.
Publicado: (2021)

Binding of inhibitors to the monomeric and dimeric SARS-CoV-2 Mpro
por: Tam, Nguyen Minh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gvc2si16vpvpglt2drje0pqat1